News & Updates

Show Multimedia Only
Delgocitinib ointment safely reduces symptoms in paediatric atopic dermatitis

Delgocitinib ointment safely reduces symptoms in paediatric atopic dermatitis

31 Oct 2025 byStephen Padilla

Treatment with delgocitinib ointment, a topical Janus kinase (JAK) inhibitor, for paediatric atopic dermatitis (AD) is effective and well tolerated when applied for up to 56 weeks, according to a phase III trial and a subsequent open-label, long-term study in Japan.

Delgocitinib ointment safely reduces symptoms in paediatric atopic dermatitis

31 Oct 2025